NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection
NHS england
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHS england, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHS england awarded this contract to Janssen-Cilag Ltd | Zentiva Pharma UK Ltd | Teva UK Limited | Mylan | Mercury Pharmaceuticals Limited worth £27,009,807 on 28 Mar 2023. The contract runs until 31 Jan 2025.
Description
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection
Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:
CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 - 30/04/2024 - (12 Months) LSNE 01/05/2023 - 30/04/2024 - (12 Months) NWLN 01/05/2023 - 30/04/2024 - (12 Months)
CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 - 31/05/2024 (13 Months) NWLN 01/05/2023 - 31/01/2025 (21 months)
Awarded suppliers (5)
- Janssen-Cilag Ltd
- Zentiva Pharma UK Ltd
- Teva UK Limited
- Mylan
- Mercury Pharmaceuticals Limited
Contact
Identifiers
Explore related tenders
Other tenders from NHS england
View all →External ID: cf-ocds-b5fd17-c5f1ad7d-fcac-4ac7-bdd9-f6fe1f150616 • Added 4 October 2026